symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
MLCT,0.16,2.332872,11896,12936015,0,0.1-0.25,0.01,"Malachite Innovations, Inc.",USD,0001438943,US56089M1071,56089M107,Other OTC,PNK,Biotechnology,https://malachiteinnovations.com,"Malachite Innovations, Inc., together with its subsidiaries, provides health and wellness products in the United States. It offers a portfolio of approximately 100 novel cannabosides, including glycosylated tetrahydrocannabinol, cannabidiol, cannabidivarin, and cannabinol. The company also develops THC-glycoside (VBX-100), an oral prodrug for the treatment of gastrointestinal diseases, including inflammatory bowel disease and irritable bowel syndrome. In addition, it engages in identifying, investing in, and repositioning environmental situations with a focus on technological innovations and eco-friendly solutions. The company was formerly known as Vitality Biopharma, Inc. and changed its name to Malachite Innovations, Inc. in October 2021. Malachite Innovations, Inc. was incorporated in 2007 and is headquartered in Cleveland, Ohio.","Mr. Michael R. Cavanaugh CPA, J.D.",Healthcare,US,38,216 304 6556,200 Park Avenue,Cleveland,OH,44122,,0,https://financialmodelingprep.com/image-stock/MLCT.png,2012-03-27,False,False,True,False,False
